Taylor Wealth Management Partners Halozyme Therapeutics, Inc. Transaction History

Taylor Wealth Management Partners

$176 Million
Q2 2022

A detailed history of Taylor Wealth Management Partners transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Taylor Wealth Management Partners holds 78,071 shares of HALO stock, worth $4.91 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares

78,071

Previous 82,384 5.24%

Holding current value

$4.91 Million

Previous $3.29 Million 4.57%

% of portfolio

1.95%

Previous 1.33%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$37.35 - $48.3 $161,090 - $208,317	-4,313 Reduced 5.24%	78,071 $3.44 Million
Q1 2022 May 11, 2022	SELL	$31.97 - $41.06 $145,623 - $187,028	-4,555 Reduced 5.24%	82,384 $3.29 Million
Q4 2021 Jan 28, 2022	SELL	$31.82 - $40.75 $22,751 - $29,136	-715 Reduced 0.82%	86,939 $3.5 Million
Q3 2021 Oct 26, 2021	BUY	$38.47 - $46.42 $86,365 - $104,212	2,245 Added 2.63%	87,654 $3.57 Million
Q2 2021 Aug 11, 2021	SELL	$38.84 - $51.31 $69,601 - $91,947	-1,792 Reduced 2.06%	85,409 $3.88 Million
Q1 2021 Apr 21, 2021	SELL	$39.51 - $51.45 $68,747 - $89,523	-1,740 Reduced 1.96%	87,201 $3.64 Million
Q4 2020 Feb 02, 2021	BUY	$25.81 - $43.62 $53,813 - $90,947	2,085 Added 2.4%	88,941 $3.8 Million
Q3 2020 Oct 14, 2020	BUY	$25.74 - $29.63 $26,718 - $30,755	1,038 Added 1.21%	86,856 $2.28 Million
Q2 2020 Jul 27, 2020	SELL	$16.25 - $26.81 $35,311 - $58,258	-2,173 Reduced 2.47%	85,818 $2.3 Million
Q1 2020 May 04, 2020	BUY	$13.9 - $21.83 $3,127 - $4,911	225 Added 0.26%	87,991 $1.58 Million
Q4 2019 Jan 30, 2020	SELL	$14.93 - $19.53 $1.74 Million - $2.27 Million	-116,323 Reduced 57.0%	87,766 $1.56 Million
Q3 2019 Oct 17, 2019	SELL	$15.2 - $17.69 $15,124 - $17,601	-995 Reduced 0.49%	204,089 $3.17 Million
Q2 2019 Jul 17, 2019	BUY	$14.75 - $17.26 $10,841 - $12,686	735 Added 0.36%	205,084 $3.52 Million
Q1 2019 May 14, 2019	BUY	$13.94 - $17.58 $1,003 - $1,265	72 Added 0.04%	204,349 $3.29 Million
Q4 2018 Jan 14, 2019	SELL	$13.33 - $18.66 $227,982 - $319,141	-17,103 Reduced 7.73%	204,277 $2.99 Million
Q3 2018 Oct 23, 2018	BUY	$16.68 - $18.41 $15,095 - $16,661	905 Added 0.41%	221,380 $4.02 Million
Q2 2018 Jul 27, 2018	SELL	$16.87 - $20.3 $3,289 - $3,958	-195 Reduced 0.09%	220,475 $3.72 Million
Q1 2018 Apr 11, 2018	BUY	$17.06 - $21.2 $1.01 Million - $1.25 Million	58,995 Added 36.49%	220,670 $4.32 Million
Q4 2017 Feb 01, 2018	BUY	$16.75 - $20.8 $20,351 - $25,272	1,215 Added 0.76%	161,675 $3.28 Million
Q3 2017 Oct 13, 2017	BUY	$11.76 - $17.4 $1.89 Million - $2.79 Million	160,460	160,460 $2.79 Million

Others Institutions Holding HALO

# of Institutions

582

Shares Held

122M

Call Options Held

308K

Put Options Held

186K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.76B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Wealth Management Partners with notifications on news.

Account

Taylor Wealth Management Partners Halozyme Therapeutics, Inc. Transaction History